Dr. Reddy’s, Torrent Pharma and Laurus Synthesis all land Form 483 letters following FDA inspections

In December, the FDA hit India-based Torrent Pharmaceuticals, Laurus Synthesis and Dr. Reddy's Laboratories, each with Form 483 letters published on December 28. This was Dr. Reddy's second letter to the same facility in just two months.

In the last 12 page letter For Dr. Reddy's site located in Telangana, India, the FDA noted in detail three observations found between December 4 and 8. First form 483 for the generic drug giant following an inspection in October.